Terms: = Uterine cancer AND CEACAM5, CEA AND Diagnosis
144 results:
1. Cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
2. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract] [Full Text] [Related]
3. It is more than uterine fibroids: Incidental discovery of adenoma malignum of the cervix.
Abada E
Malays J Pathol; 2022 Dec; 44(3):533-538. PubMed ID: 36591722
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
6. Human papillomavirus integration perspective in small cell cervical carcinoma.
Wang X; Jia W; Wang M; Liu J; Zhou X; Liang Z; Zhang Q; Long S; Quzhen S; Li X; Tian Q; Li X; Sun H; Zhao C; Meng S; Ning R; Xi L; Wang L; Zhou S; Zhang J; Wu L; Chen Y; Liu A; Ma Y; Zhao X; Cheng X; Zhang Q; Han X; Pan H; Zhang Y; Cao L; Wang Y; Ling S; Cao L; Xing H; Xu C; Sui L; Wang S; Zhou J; Kong B; Xie X; Chen G; Li S; Ma D; Li S
Nat Commun; 2022 Oct; 13(1):5968. PubMed ID: 36216793
[TBL] [Abstract] [Full Text] [Related]
7. A microfluidic chip using Au@SiO
Gu Y; Li Z; Ge S; Mao Y; Gu Y; Cao X; Lu D
Anal Bioanal Chem; 2022 Nov; 414(26):7659-7673. PubMed ID: 36050486
[TBL] [Abstract] [Full Text] [Related]
8. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer.
Unuvar S; Melekoglu R; Turkmen NB; Yilmaz E; Yasar S; Yuce H
Int J Gynaecol Obstet; 2021 Dec; 155(3):417-424. PubMed ID: 33660848
[TBL] [Abstract] [Full Text] [Related]
10. A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Ge L; Liu G; Hu K; Huang K; Zhang M; Zhou J; Teng F; Cao J; Dai C; Jia X
Technol Cancer Res Treat; 2020; 19():1533033819901117. PubMed ID: 32167027
[TBL] [Abstract] [Full Text] [Related]
11. The potential of ciRS-7 for predicting onset and prognosis of cervical cancer.
Zhou Y; Shen L; Wang YZ; Zhou CC
Neoplasma; 2020 Mar; 67(2):312-322. PubMed ID: 31884800
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract] [Full Text] [Related]
13. Primary Peritoneal Low-grade Serous Carcinoma in a Patient With Lynch Syndrome: A Case Report.
Makiuchi S; Yoshida H; Ishikawa M; Kojima N; Kanai Y; Kato T
Int J Gynecol Pathol; 2020 Jul; 39(4):327-332. PubMed ID: 31274699
[TBL] [Abstract] [Full Text] [Related]
14. PHENOTYPIC CHARACTERISTICS OF CHORIONIC VILLI DURING GESTATIONAL TROPHOBLASTIC DISEASES.
Chikvaidze N; Kintraia N; Muzashvili T; Gachechiladze M; Burkadze G
Georgian Med News; 2019 Jan; (286):140-145. PubMed ID: 30829607
[TBL] [Abstract] [Full Text] [Related]
15. CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding.
Nithin KU; Sridhar MG; Srilatha K; Habebullah S
Afr Health Sci; 2018 Dec; 18(4):972-978. PubMed ID: 30766562
[TBL] [Abstract] [Full Text] [Related]
16. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract] [Full Text] [Related]
17. [Genital metastases from breast cancer: study of 3 cases and literature review].
Zoukar O; Haddad A; Daldoul A; Zaied S; Salem AB; Zouari I; Faleh R
Pan Afr Med J; 2018; 30():7. PubMed ID: 30123410
[TBL] [Abstract] [Full Text] [Related]
18. Cost-effectiveness analysis of biopsy strategies for endometrial cancer diagnosis in women with postmenopausal bleeding: Pipelle sampling curette versus dilatation & curettage.
Yi Y; Bryce CL; Adambekov S; Edwards RP; Goughnour SL; Linkov F
Gynecol Oncol; 2018 Jul; 150(1):112-118. PubMed ID: 29747864
[TBL] [Abstract] [Full Text] [Related]
19. A dual-label time-resolved fluorescence immunoassay for the simultaneous determination of carcinoembryonic antigen and squamous cell carcinoma antigen.
Mao Q; Liu X; Chen C; Ye J; Liang H; Li B; Sun X; Sun L; Sun Y; Mu X; Li L
Biotechnol Appl Biochem; 2018 Nov; 65(6):816-821. PubMed ID: 29679420
[TBL] [Abstract] [Full Text] [Related]
20. Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.
de Kok IMCM; Korfage IJ; van den Hout WB; Helmerhorst TJM; Habbema JDF; Essink-Bot ML; van Ballegooijen M
Int J Cancer; 2018 Jun; 142(11):2383-2393. PubMed ID: 29349795
[TBL] [Abstract] [Full Text] [Related]
[Next]
